This paper is in the following e-collection/theme issue:

Formative Evaluation of Digital Health Interventions (2512) Registered Report (580) e-Learning and Digital Medical Education (710) Health Professionals' Training in eHealth, Digital Medicine, Medical Informatics (112) Cross-Sectional Studies in Public Health (289) Continuing Medical Education (CME) for Allied Health Professionals (134) Pilot studies (ehealth) (216)

Published on in Vol 8 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/54656, first published .
Evaluation of an e-Learning Program for Community Pharmacists for Dispensing Emicizumab (Hemlibra) in France: Nationwide Cross-Sectional Study

Evaluation of an e-Learning Program for Community Pharmacists for Dispensing Emicizumab (Hemlibra) in France: Nationwide Cross-Sectional Study

Evaluation of an e-Learning Program for Community Pharmacists for Dispensing Emicizumab (Hemlibra) in France: Nationwide Cross-Sectional Study

Authors of this article:

Valérie Chamouard1 Author Orcid Image ;   Julie Freyssenge2 Author Orcid Image ;   Béatrice Clairaz-Mahiou3 Author Orcid Image ;   Felicia Ferrera Bibas4 Author Orcid Image ;   Laurie Fraticelli5 Author Orcid Image
Article Authors Cited by (1) Tweetations (2) Metrics

Journals

  1. Cabon M, Chamouard V, Freyssenge J, Fraticelli L. Comparative evaluation of access to emicizumab (Hemlibra®) for people with haemophilia A in community and hospital pharmacies in France. European Journal of Public Health 2024;34(5):866 View